Literature DB >> 1986167

Studies of myocardial protection in the immature heart. IV. Improved tolerance of immature myocardium to hypoxia and ischemia by intravenous metabolic support.

P Julia1, H H Young, G D Buckberg, E R Kofsky, H I Bugyi.   

Abstract

Thirteen immature puppies (2 to 4 kg) underwent 1 hour of acute hypoxia (oxygen tension 25 to 30 mm Hg), followed by 45 minutes of normothermic global ischemia on total vented bypass with normal blood reperfusion. Ventricular function was assessed by inscribing Starling function curves and measuring stroke work indices before hypoxia and after reperfusion. Seven puppies (control) received normal saline infusion at 4 ml/kg/hr. Six other puppies received a 4 ml/kg/hr intravenous infusion of glutamate/aspartate, glucose-insulin-potassium, mercaptopropionyl glycine, carnitine, and catalase during hypoxia and reperfusion. In control hearts, acute hypoxia depleted myocardial glutamate and aspartate by 52% (p less than 0.05 versus prehypoxia) and 48% (p less than 0.05 versus prehypoxia) and caused severe hemodynamic deterioration (55% decrease of stroke work index) (p less than 0.05 versus prehypoxia); three of seven (43%) required premature institution of bypass. Postischemic left ventricular function recovered to only 40% of control levels (p less than 0.05 versus prehypoxia). In contrast, intravenous metabolic infusions maintained tissue glutamate (p less than 0.05 versus control group) and aspartate (p less than 0.05 versus control group) in treated hearts during hypoxia and allowed cardiac index to rise 20% (p less than 0.05 versus prehypoxia); all treated hearts tolerated 1 hour of hypoxia, and stroke work recovered 70% (p less than 0.05 versus control group) of stroke work index after subsequent ischemia. Impaired tolerance of immature hearts to acute hypoxia and subsequent ischemia is due to substrate depletion. This impairment can be reduced by intravenous metabolic support during hypoxia and reperfusion and leads to improved recovery of postischemic function.

Entities:  

Mesh:

Year:  1991        PMID: 1986167

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Myocardial protection during surgical intervention for treatment of acute myocardial infarction.

Authors:  F Beyersdorf; G D Buckberg
Journal:  Tex Heart Inst J       Date:  1992

2.  Controlled reoxygenation cardiopulmonary bypass is associated with reduced transcriptomic changes in cyanotic tetralogy of Fallot patients undergoing surgery.

Authors:  Mohamed T Ghorbel; Amir Mokhtari; Maimuna Sheikh; Gianni D Angelini; Massimo Caputo
Journal:  Physiol Genomics       Date:  2012-09-18       Impact factor: 3.107

3.  Normoxic and hyperoxic cardiopulmonary bypass in congenital heart disease.

Authors:  Amir Mokhtari; Martin Lewis
Journal:  Biomed Res Int       Date:  2014-09-18       Impact factor: 3.411

4.  Effect of esmolol on myocardial protection in pediatrics congenital heart defects.

Authors:  Saeed Fazelifar; Hamid Bigdelian
Journal:  Adv Biomed Res       Date:  2015-11-23

5.  Myocardial oxygen consumption during histidine-tryptophan-ketoglutarate cardioplegia in young human hearts.

Authors:  Emanuela Angeli; Sabrina Martens; Lucio Careddu; Francesco D Petridis; Andrea G Quarti; Cristina Ciuca; Anna Balducci; Assunta Fabozzo; Luca Ragni; Andrea Donti; Gaetano D Gargiulo
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-01-22

Review 6.  Oxidative Stress after Surgery on the Immature Heart.

Authors:  Daniel Fudulu; Gianni Angelini
Journal:  Oxid Med Cell Longev       Date:  2016-03-31       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.